The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Rapid Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
The global Rapid Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Rapid Diagnostics in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Rapid Diagnostics market. Over-the-Counter (OTC) Rapid Diagnostics Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Professional Rapid Diagnostics Test segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rapid Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rapid Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rapid Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rapid Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rapid Diagnostics covered in this report include Roche Diagnostics, Abbott, Siemens Healthcare, Abbott Diagnostics, Beckman Coulter, BD, Abaxis, Bayer HealthCare and Clarity Diagnostics, etc.
The global Rapid Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Abbott
Siemens Healthcare
Abbott Diagnostics
Beckman Coulter
BD
Abaxis
Bayer HealthCare
Clarity Diagnostics
DiagCor Bioscience
Eiken Chemical
GlySens
OraSure Technologies
Trivitron Healthcare
Randox Laboratories
Sysmex
Nipro Diagnostics
Oasis Diagnostics
Helena Laboratories
Humor Diagnostica
Global Rapid Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rapid Diagnostics market, Segment by Type:
Over-the-Counter (OTC) Rapid Diagnostics Test
Professional Rapid Diagnostics Test
Global Rapid Diagnostics market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Rapid Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Rapid Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Rapid Diagnostics in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Rapid Diagnostics market. Over-the-Counter (OTC) Rapid Diagnostics Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Professional Rapid Diagnostics Test segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rapid Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rapid Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rapid Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rapid Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rapid Diagnostics covered in this report include Roche Diagnostics, Abbott, Siemens Healthcare, Abbott Diagnostics, Beckman Coulter, BD, Abaxis, Bayer HealthCare and Clarity Diagnostics, etc.
The global Rapid Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Abbott
Siemens Healthcare
Abbott Diagnostics
Beckman Coulter
BD
Abaxis
Bayer HealthCare
Clarity Diagnostics
DiagCor Bioscience
Eiken Chemical
GlySens
OraSure Technologies
Trivitron Healthcare
Randox Laboratories
Sysmex
Nipro Diagnostics
Oasis Diagnostics
Helena Laboratories
Humor Diagnostica
Global Rapid Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rapid Diagnostics market, Segment by Type:
Over-the-Counter (OTC) Rapid Diagnostics Test
Professional Rapid Diagnostics Test
Global Rapid Diagnostics market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Rapid Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Rapid Diagnostics
1.1 Rapid Diagnostics Market Overview
1.1.1 Rapid Diagnostics Product Scope
1.1.2 Rapid Diagnostics Market Status and Outlook
1.2 Global Rapid Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Rapid Diagnostics Market Size by Region (2018-2029)
1.4 Global Rapid Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Rapid Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Rapid Diagnostics Market Size (2018-2029)
1.6.1 North America Rapid Diagnostics Market Size (2018-2029)
1.6.2 Europe Rapid Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Rapid Diagnostics Market Size (2018-2029)
1.6.4 Latin America Rapid Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Rapid Diagnostics Market Size (2018-2029)
2 Rapid Diagnostics Market by Type
2.1 Introduction
2.1.1 Over-the-Counter (OTC) Rapid Diagnostics Test
2.1.2 Professional Rapid Diagnostics Test
2.2 Global Rapid Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Rapid Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Rapid Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
3 Rapid Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Rapid Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Rapid Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Rapid Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
4 Rapid Diagnostics Competition Analysis by Players
4.1 Global Rapid Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rapid Diagnostics as of 2022)
4.3 Date of Key Players Enter into Rapid Diagnostics Market
4.4 Global Top Players Rapid Diagnostics Headquarters and Area Served
4.5 Key Players Rapid Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Rapid Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche Diagnostics
5.1.1 Roche Diagnostics Profile
5.1.2 Roche Diagnostics Main Business
5.1.3 Roche Diagnostics Rapid Diagnostics Products, Services and Solutions
5.1.4 Roche Diagnostics Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Diagnostics Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Rapid Diagnostics Products, Services and Solutions
5.2.4 Abbott Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Siemens Healthcare
5.3.1 Siemens Healthcare Profile
5.3.2 Siemens Healthcare Main Business
5.3.3 Siemens Healthcare Rapid Diagnostics Products, Services and Solutions
5.3.4 Siemens Healthcare Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Diagnostics Recent Developments
5.4 Abbott Diagnostics
5.4.1 Abbott Diagnostics Profile
5.4.2 Abbott Diagnostics Main Business
5.4.3 Abbott Diagnostics Rapid Diagnostics Products, Services and Solutions
5.4.4 Abbott Diagnostics Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Diagnostics Recent Developments
5.5 Beckman Coulter
5.5.1 Beckman Coulter Profile
5.5.2 Beckman Coulter Main Business
5.5.3 Beckman Coulter Rapid Diagnostics Products, Services and Solutions
5.5.4 Beckman Coulter Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Beckman Coulter Recent Developments
5.6 BD
5.6.1 BD Profile
5.6.2 BD Main Business
5.6.3 BD Rapid Diagnostics Products, Services and Solutions
5.6.4 BD Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 BD Recent Developments
5.7 Abaxis
5.7.1 Abaxis Profile
5.7.2 Abaxis Main Business
5.7.3 Abaxis Rapid Diagnostics Products, Services and Solutions
5.7.4 Abaxis Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Abaxis Recent Developments
5.8 Bayer HealthCare
5.8.1 Bayer HealthCare Profile
5.8.2 Bayer HealthCare Main Business
5.8.3 Bayer HealthCare Rapid Diagnostics Products, Services and Solutions
5.8.4 Bayer HealthCare Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Bayer HealthCare Recent Developments
5.9 Clarity Diagnostics
5.9.1 Clarity Diagnostics Profile
5.9.2 Clarity Diagnostics Main Business
5.9.3 Clarity Diagnostics Rapid Diagnostics Products, Services and Solutions
5.9.4 Clarity Diagnostics Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Clarity Diagnostics Recent Developments
5.10 DiagCor Bioscience
5.10.1 DiagCor Bioscience Profile
5.10.2 DiagCor Bioscience Main Business
5.10.3 DiagCor Bioscience Rapid Diagnostics Products, Services and Solutions
5.10.4 DiagCor Bioscience Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 DiagCor Bioscience Recent Developments
5.11 Eiken Chemical
5.11.1 Eiken Chemical Profile
5.11.2 Eiken Chemical Main Business
5.11.3 Eiken Chemical Rapid Diagnostics Products, Services and Solutions
5.11.4 Eiken Chemical Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Eiken Chemical Recent Developments
5.12 GlySens
5.12.1 GlySens Profile
5.12.2 GlySens Main Business
5.12.3 GlySens Rapid Diagnostics Products, Services and Solutions
5.12.4 GlySens Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 GlySens Recent Developments
5.13 OraSure Technologies
5.13.1 OraSure Technologies Profile
5.13.2 OraSure Technologies Main Business
5.13.3 OraSure Technologies Rapid Diagnostics Products, Services and Solutions
5.13.4 OraSure Technologies Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 OraSure Technologies Recent Developments
5.14 Trivitron Healthcare
5.14.1 Trivitron Healthcare Profile
5.14.2 Trivitron Healthcare Main Business
5.14.3 Trivitron Healthcare Rapid Diagnostics Products, Services and Solutions
5.14.4 Trivitron Healthcare Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Trivitron Healthcare Recent Developments
5.15 Randox Laboratories
5.15.1 Randox Laboratories Profile
5.15.2 Randox Laboratories Main Business
5.15.3 Randox Laboratories Rapid Diagnostics Products, Services and Solutions
5.15.4 Randox Laboratories Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Randox Laboratories Recent Developments
5.16 Sysmex
5.16.1 Sysmex Profile
5.16.2 Sysmex Main Business
5.16.3 Sysmex Rapid Diagnostics Products, Services and Solutions
5.16.4 Sysmex Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.16.5 Sysmex Recent Developments
5.17 Nipro Diagnostics
5.17.1 Nipro Diagnostics Profile
5.17.2 Nipro Diagnostics Main Business
5.17.3 Nipro Diagnostics Rapid Diagnostics Products, Services and Solutions
5.17.4 Nipro Diagnostics Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.17.5 Nipro Diagnostics Recent Developments
5.18 Oasis Diagnostics
5.18.1 Oasis Diagnostics Profile
5.18.2 Oasis Diagnostics Main Business
5.18.3 Oasis Diagnostics Rapid Diagnostics Products, Services and Solutions
5.18.4 Oasis Diagnostics Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.18.5 Oasis Diagnostics Recent Developments
5.19 Helena Laboratories
5.19.1 Helena Laboratories Profile
5.19.2 Helena Laboratories Main Business
5.19.3 Helena Laboratories Rapid Diagnostics Products, Services and Solutions
5.19.4 Helena Laboratories Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.19.5 Helena Laboratories Recent Developments
5.20 Humor Diagnostica
5.20.1 Humor Diagnostica Profile
5.20.2 Humor Diagnostica Main Business
5.20.3 Humor Diagnostica Rapid Diagnostics Products, Services and Solutions
5.20.4 Humor Diagnostica Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.20.5 Humor Diagnostica Recent Developments
6 North America
6.1 North America Rapid Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Rapid Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Rapid Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Rapid Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Rapid Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Rapid Diagnostics Market Dynamics
11.1 Rapid Diagnostics Industry Trends
11.2 Rapid Diagnostics Market Drivers
11.3 Rapid Diagnostics Market Challenges
11.4 Rapid Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
